End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.17 CNY | -0.08% | +2.11% | -3.44% |
05-07 | US FDA Grants Clinical Trial Approval for Fosun Unit's Gastric Cancer Tablets | MT |
04-30 | Fosun Pharma's Q1 Profit Slumps 38% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 7.99B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.94% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator